IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,217,438 | -13.1% | 485,886 | +0.4% | 0.02% | -10.0% |
| Q2 2023 | $29,006,074 | +29.3% | 483,757 | +6.6% | 0.02% | +25.0% |
| Q1 2023 | $22,436,069 | -21.7% | 453,804 | -9.6% | 0.02% | -27.3% |
| Q4 2022 | $28,648,172 | +16.0% | 501,983 | -4.6% | 0.02% | +10.0% |
| Q3 2022 | $24,703,000 | +120.7% | 526,252 | +75.4% | 0.02% | +150.0% |
| Q2 2022 | $11,191,000 | +58.9% | 299,950 | +27.3% | 0.01% | +100.0% |
| Q1 2022 | $7,043,000 | -12.3% | 235,545 | +0.5% | 0.00% | -20.0% |
| Q4 2021 | $8,027,000 | +17.1% | 234,439 | +26.8% | 0.01% | +25.0% |
| Q3 2021 | $6,855,000 | -0.9% | 184,925 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $6,916,000 | +31.5% | 177,105 | +43.3% | 0.00% | 0.0% |
| Q1 2021 | $5,260,000 | – | 123,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |